CN105602889A - 用于哺乳动物来源的神经胶质限制性祖细胞的扩增、鉴定、表征和效能增强的方法和组合物 - Google Patents

用于哺乳动物来源的神经胶质限制性祖细胞的扩增、鉴定、表征和效能增强的方法和组合物 Download PDF

Info

Publication number
CN105602889A
CN105602889A CN201610055313.6A CN201610055313A CN105602889A CN 105602889 A CN105602889 A CN 105602889A CN 201610055313 A CN201610055313 A CN 201610055313A CN 105602889 A CN105602889 A CN 105602889A
Authority
CN
China
Prior art keywords
cell
grp
positive
days
div
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610055313.6A
Other languages
English (en)
Chinese (zh)
Inventor
罗伯特·桑德罗克
詹姆斯·T·坎帕内利
德波拉·A·埃普斯泰因
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Therapeutics Inc
Q Therapeutics Inc
Original Assignee
Q Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Q Therapeutics Inc filed Critical Q Therapeutics Inc
Publication of CN105602889A publication Critical patent/CN105602889A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
CN201610055313.6A 2009-11-12 2010-11-09 用于哺乳动物来源的神经胶质限制性祖细胞的扩增、鉴定、表征和效能增强的方法和组合物 Pending CN105602889A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26044109P 2009-11-12 2009-11-12
US61/260,441 2009-11-12
US32679910P 2010-04-22 2010-04-22
US61/326,799 2010-04-22
CN201080051269.2A CN102686721B (zh) 2009-11-12 2010-11-09 用于哺乳动物来源的神经胶质限制性祖细胞的扩增、鉴定、表征和效能增强的方法和组合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201080051269.2A Division CN102686721B (zh) 2009-11-12 2010-11-09 用于哺乳动物来源的神经胶质限制性祖细胞的扩增、鉴定、表征和效能增强的方法和组合物

Publications (1)

Publication Number Publication Date
CN105602889A true CN105602889A (zh) 2016-05-25

Family

ID=43991980

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201610055313.6A Pending CN105602889A (zh) 2009-11-12 2010-11-09 用于哺乳动物来源的神经胶质限制性祖细胞的扩增、鉴定、表征和效能增强的方法和组合物
CN201080051269.2A Active CN102686721B (zh) 2009-11-12 2010-11-09 用于哺乳动物来源的神经胶质限制性祖细胞的扩增、鉴定、表征和效能增强的方法和组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201080051269.2A Active CN102686721B (zh) 2009-11-12 2010-11-09 用于哺乳动物来源的神经胶质限制性祖细胞的扩增、鉴定、表征和效能增强的方法和组合物

Country Status (11)

Country Link
US (2) US10351823B2 (https=)
EP (2) EP2499238B1 (https=)
JP (2) JP5952737B2 (https=)
CN (2) CN105602889A (https=)
AU (1) AU2010319680B2 (https=)
CA (1) CA2780541C (https=)
DK (1) DK2499238T3 (https=)
ES (1) ES2649396T3 (https=)
NO (1) NO2499238T3 (https=)
PL (1) PL2499238T3 (https=)
WO (1) WO2011059952A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070171A2 (en) 2002-02-15 2003-08-28 Cornell Research Foundation, Inc. Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
KR20110011658A (ko) 2008-05-08 2011-02-08 유니버시티 오브 로체스터 최적화된 세포 제제에 의한 수초 질환의 치료
JP6541577B2 (ja) 2013-02-06 2019-07-10 ユニバーシティー オブ ロチェスター ミエリン障害の治療のための誘導多能性細胞由来オリゴデンドロサイト前駆細胞
CA2959691A1 (en) * 2014-09-26 2016-03-31 The Procter & Gamble Company Products comprising malodor reduction materials
US9724432B2 (en) 2015-04-30 2017-08-08 University Of Rochester Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
US11690876B2 (en) 2017-05-10 2023-07-04 University Of Rochester Methods of treating neuropsychiatric disorders
CN108624560B (zh) * 2018-06-01 2022-04-08 南京艾尔普再生医学科技有限公司 一种分化培养基及少突胶质前体细胞的制备方法
US10995325B2 (en) 2019-03-21 2021-05-04 Fornia Biosolutions, Inc. Additional phytase variants and methods
KR102322635B1 (ko) * 2021-06-11 2021-11-05 인제대학교 산학협력단 말초신경양 미세조직 제조방법 및 이의 용도
US20240254440A1 (en) * 2021-06-30 2024-08-01 The Regents Of The University Of California Methods to generate glial restricted neural progenitor cells and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070037222A1 (en) * 1997-07-04 2007-02-15 Rao Mahendra S Lineage restricted glial precursors
US20080138895A1 (en) * 1999-10-25 2008-06-12 Lars Wahlberg Cultures of gfap+ nestin+ cells that differentiate to neurons

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2295197A1 (en) 1999-09-08 2001-03-08 Appleton Papers Inc. Thermally-responsive record material
AR046076A1 (es) * 2003-07-18 2005-11-23 Otsuka Pharma Co Ltd Procedimiento para obtener una poblacion homogenea de celulas precursoras de oligodendrocitos y poblacion obtenida
US20050272149A1 (en) * 2004-06-02 2005-12-08 Life & Brain Gmbh Therapeutic delivery of adenosine into a tissue
US20090155223A1 (en) * 2007-08-14 2009-06-18 The Johns Hopkins University Cell-based compositions and methods for treating conditions of the nervous system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070037222A1 (en) * 1997-07-04 2007-02-15 Rao Mahendra S Lineage restricted glial precursors
US20080138895A1 (en) * 1999-10-25 2008-06-12 Lars Wahlberg Cultures of gfap+ nestin+ cells that differentiate to neurons

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HUAIYU MI等: "Purification and Characterization of Astrocyte Precursor Cells in the Developing Rat Optic Nerve", 《THE JOURNAL OF NEUROSCIENCE》 *

Also Published As

Publication number Publication date
CN102686721B (zh) 2016-02-10
JP6346629B2 (ja) 2018-06-20
EP2499238A1 (en) 2012-09-19
HK1174953A1 (zh) 2013-06-21
EP2499238B1 (en) 2017-08-30
JP2016146831A (ja) 2016-08-18
EP3269803A2 (en) 2018-01-17
AU2010319680B2 (en) 2014-05-29
NO2499238T3 (https=) 2018-01-27
CA2780541C (en) 2015-07-14
PL2499238T3 (pl) 2018-04-30
DK2499238T3 (en) 2017-12-04
ES2649396T3 (es) 2018-01-11
EP3269803A3 (en) 2018-04-25
WO2011059952A1 (en) 2011-05-19
US20120230963A1 (en) 2012-09-13
CA2780541A1 (en) 2011-05-19
EP2499238A4 (en) 2013-10-02
US10351823B2 (en) 2019-07-16
CN102686721A (zh) 2012-09-19
JP2013510570A (ja) 2013-03-28
AU2010319680A1 (en) 2012-07-05
US20190032010A1 (en) 2019-01-31
JP5952737B2 (ja) 2016-07-13

Similar Documents

Publication Publication Date Title
US12178834B2 (en) Treating myelin diseases with optimized cell preparations
CN105602889A (zh) 用于哺乳动物来源的神经胶质限制性祖细胞的扩增、鉴定、表征和效能增强的方法和组合物
Barak et al. Human iPSC-derived neural models for studying Alzheimer’s disease: from neural stem cells to cerebral organoids
JP6673966B2 (ja) 神経変性を治療するための方法及び組成物
Johnson et al. Development and characterization of an adult retinal explant organotypic tissue culture system as an in vitro intraocular stem cell transplantation model
Zheng et al. Differentiation of glial cells from hiPSCs: potential applications in neurological diseases and cell replacement therapy
US20060247195A1 (en) Method of altering cell properties by administering rna
CN102325878A (zh) 少突胶质前体细胞的靶向细胞群及制备与使用方法
CN103146649A (zh) 神经干细胞
KR20060037346A (ko) 휘돌기교세포 전구세포 및 이를 획득하고 배양하는 방법
Lin et al. Role of HIF-1α-activated Epac1 on HSC-mediated neuroplasticity in stroke model
CN101124319B (zh) 神经干细胞
CN112154203B (zh) 高效分离和培养神经干细胞的方法
US20250325710A1 (en) Advanced In Vivo Platform to Study Human Neural Maturation and Circuit Integration
CN117652457A (zh) 神经退行性疾病啮齿动物模型的制备方法及其用途
JP2004520051A (ja) 腸管神経系に由来する幹細胞および前駆細胞ならびにそれらの使用
JP2004520051A6 (ja) 腸管神経系に由来する幹細胞および前駆細胞ならびにそれらの使用
Jaberi et al. Transplanted autologous neural stem cells show promise in restoring motor function in monkey spinal cord injury
Simeonova Generation of Defined Astrocytic Phenotypes from Human Pluripotent Stem Cells for Transplantation after Spinal Cord Injury
Bonner et al. Cellular replacement in spinal cord injury
Zhang et al. Anindita Sarkar, Salk Institute for Biological Studies, United States Serhiy Forostyak, Charles University, Czechia
HK1174953B (en) Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160525